Genetic Technologies has received its clinical laboratory permit from the New York State Department of Health (DoH). Genetic Technologies received a positive Laboratory Evaluation Report with "No significant deficiencies" following an ...
Tags: Health, Medicine, Genetic Technologies
Phenogen Sciences, a subsidiary of Genetic Technologies, has unveiled a non-invasive genetic risk assessment test for women with estrogen-receptor positive breast cancer. The BREVAGen uses patients oral-swab samples to calculate patient's ...
Tags: non-invasive genetic risk assessment test, cancer test
Phenogen Sciences has announced the availability of BREVAGen Breast cancer risk assessment test for women at above average risk of developing estrogen-receptor positive breast cancer. The risk assessment test, which combines clinical ...
Tags: medical research, clinical technology, risk assessment test